USPTO serial 76196314
FORTEOS
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCMORROW, RONALD G
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FORTEOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David E Kirtley
DAVID E KIRTLEY TRADEMARK DEPT DROP CODE 1098ELI LILLY AND COMPANYLILLY CORPORATE CTRINDIANAPOLIS, IN 46285-0001Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations, namely for the prevention and treatment of bone/skeletal diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2002 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Nov 13, 2001 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 23, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 3, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| May 8, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 7, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2001 | DOCK | ASSIGNED TO EXAMINER | — |